(1888PressRelease)
October 30, 2008 - EVIALIS of France, a manufacturer of animal-feed additives, will launch its NEOVIA range of high-performance animal nutrition products at the Euro tier Exhibition, which will be held in Hanover from 11 to 14 November 2008. The company will hold a press conference at 3pm on 12 November to present the range.
The five products in the NEOVIA range are T5X, which stimulates natural detoxification; B-Safe, which boosts the gastro-intestinal defence mechanisms; Stimune, which promotes the transfer of immunity in piglets; Oilis, which strengthens the intestinal walls and helps to control the risk of coccidiosis; and Cap’Acid, which safeguards digestion via controlled diffusion of these protected acids.
T5X acts at four complementary stages to help the animal combat mycotoxins: it binds mycotoxins by virtue of specific components, stimulates natural detoxification in the liver, prevents oxidative stress in cells and, finally, boosts the immune response. T5X offers an all-round solution for combating a wide range of mycotoxins – not only polar mycotoxins such as aflatoxins, but also less polar groups such as ZEA and DON.
B-Safe, which is based on an innovative and patented mode of action, helps to maintain the digestive balance in monogastric animals. It is comprised of plant extracts and specific clays, and limits the development of pathogenic gastro-intestinal flora whilst protecting the intestinal mucosa at the same time. B-Safe enhances the zootechnical performance results of animals and boosts breeding profitability, especially under difficult hygiene conditions.
Stimune guarantees the transfer of passive immunity and induces active immunity in newborn animals to increase the pre-weaning survival rate. Tests carried out by EVIALIS have highlighted a rise in immunoglobulin levels in the colostrum, milk and blood of piglets. As a result of greater immunity, the animals are more resistant, resulting in a 45% increase in survival rate in parturition accommodation (based on the mean result of tests carried out) and an average of up to 0.7 piglets saved per litter.
The NEOVIA range uses natural products with demonstrated effectiveness. It was developed using the company’s extensive research and development resources in order to target individual market needs more effectively. The company has a team of 100 international researchers based at five research centres across the globe (in Brazil, France, India, Indonesia and Vietnam). This strategic choice provides unparalleled reactivity. Furthermore, NEOVIA research benefits from close partnerships with universities and independent R&D centres.
In-vivo models have been implemented to test the reliability of each innovation under conditions very similar to those encountered in practice: mycotoxin challenge, coccidiosis and enterocolitis models, etc.
NEOVIA additives have been granted ISO 9001 (version 2000) and Good Manufacturing Practice (GMP) certification.
About EVIALIS
EVIALIS, which is headquartered in Vannes (in Brittany, France), is a specialist in animal health and nutrition.
The company will take part in the Euro tier Exhibition, which will be held in Hanover (Germany) from 11 to 14 November 2008 (Hall 14, Stand D20). EVIALIS will hold a press conference on Wednesday 12 November at 3pm, in the Leipzig Room (Convention Centre).
For further information, please go to: www.evialis.com
###
